Linagliptin use while Breastfeeding

Drugs containing Linagliptin: Tradjenta, Jentadueto

Linagliptin Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because no information is available on the use of linagliptin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Acarbose, Chlorpropamide, Glyburide, Insulin, Metformin, Tolbutamide

References

Linagliptin Identification

Substance Name

Linagliptin

CAS Registry Number

668270-12-0

Drug Class

Dipeptidyl-Peptidase IV Inhibitors

Administrative Information

LactMed Record Number

878

Last Revision Date

20130907

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.

Hide
(web4)